Becker's Hospital Review - Cardiology

NOVEMBER 7, 2024

A drug-eluting resorbable stent was found to be just as effective in treating infrapopliteal artery disease in patients at risk of limb amputation, according to a study published Oct. 25 in the New England Journal of Medicine.

Stents 52

Stents Stent Angioplasty Outcomes 52

DAIC

MARCH 13, 2024

milla1cf Wed, 03/13/2024 - 16:52 March 13, 2024 — In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty.

Angioplasty 116

Angioplasty Stents Stent Myocardial Infarction 116

Journal of Cardiothoracic Surgery

DECEMBER 18, 2024

This study aimed to analyze the safety and mid-term outcomes of a hybrid treatment method combining rotational atherectomy (RA) with drug-coated balloon (DCB) angioplasty in patients with femoropopliteal arter.

Angioplasty 52

Angioplasty Stents Stent Outcomes 52

American College of Cardiology

OCTOBER 29, 2024

The routine use of orbital atherectomy did not improve minimal stent area (MSA) or reduce target vessel failure (TVF) at one year compared with conventional balloon angioplasty prior to implantation of a drug-eluting stent (DES) in severely calcified coronary lesions.

Angioplasty 46

Angioplasty Stents Stent Article 46

American College of Cardiology

SEPTEMBER 2, 2024

A strategy of drug-coated balloon (DCB) angioplasty with rescue stenting did not achieve noninferiority compared with intended drug-eluting stent (DES) deployment for patients with de novo, noncomplex coronary artery lesions, according to finding from the REC-CAGEFREE I trial presented at ESC Congress 2024 in London and simultaneously published in (..)

Angioplasty 40

Angioplasty Stents Stent Article 40

DAIC

NOVEMBER 8, 2024

In the DA+DCB arm, there was a trend toward higher stent-free patency through 12 months (79.1% versus 68.1%, · P=0.09) and a significantly lower provisional stenting rate (9.5% among 6 randomized controlled trials (RCTs) (172 patients), comparing favorably to published meta-analysis rates for uncoated balloon angioplasty (47.4%

Stents 52

Stents Stent Angioplasty Peripheral Arterial Disease 52

DAIC

MARCH 1, 2024

Food and Drug Administration ( FDA ) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. ISR is the obstruction or narrowing of a stented vessel by plaque or scar tissue. vs. 28.7%; P=0.006). vs. 28.7%; P=0.006).

Stents 105

Stents Stent Coronary Artery Disease Angioplasty 105

JAMA Cardiology

DECEMBER 22, 2024

This narrative review discusses drug-coated balloon angioplasty as an alternative to drug-eluting stent for percutaneous coronary intervention in patients with in-stent restenosis and de novo coronary artery disease.

Coronary Artery Disease 73

Coronary Artery Disease Angioplasty Stents Stent 73

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Herein, we describe a single‐step approach to deploy Neuroform Atlas stent (Stryker Neurovascular, Fremont, CA) which is a hybrid laser‐cut, nitinol self‐expanding stent without the need for ELW or lesion re‐access using MINI TREK RX (Abbott Vascular, Inc., There was no restriction on time from last known well (TLKW) to MT.

Angioplasty 40

Angioplasty Stents Stent Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Background:In stroke patients undergoing EVT, angioplasty and stenting (A&S) has been described as a bailout technique when thrombectomy fails or intracranial stenosis is suspected. The stent-retriever was re-sheathed into the microcatheter before retrieval. Further prospective data is warranted.

Stents 40

Stents Stent Angioplasty Stenosis 40

American College of Cardiology

SEPTEMBER 2, 2024

The goal of the REC-CAGEFREE I trial was to assess the safety and efficacy of a paclitaxel-coated balloon (DCB) compared to drug-eluting stent (DES) implantation among patients with coronary in-stent restenosis.

Stents 44

Stents Stent Angioplasty Article 44

Stroke Journal

JANUARY 30, 2025

The objective of our study is to identify factors associated with SBIs following middle cerebral artery (MCA) stenting or balloon angioplasty.Methods:We retrospectively reviewed patients who underwent MCA stenting or balloon angioplasty, including those with symptomatic, atherosclerotic MCA stenosis of 50%.

Angioplasty 40

Angioplasty Stents Stent Stenosis 40

Medical Xpress - Cardiology

NOVEMBER 4, 2024

27 to 30 in Washington, D.C.

Angioplasty 40

Angioplasty Stents Stent 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionVertebral artery stenting represents a viable option in treating symptomatic vertebral artery atherosclerotic stenosis. We included articles reporting patients > 18 years old with symptomatic extracranial vertebral artery stenoses due to atherosclerosis treated with stenting (with or without angioplasty).

Angioplasty 40

Angioplasty Stents Stent Stenosis 40

DAIC

APRIL 11, 2024

The study, called IVUS-DCB, is the first randomized controlled trial to demonstrate the clinical benefits of using IVUS in angioplasty procedures for peripheral artery disease (PAD), a condition in which plaque builds up in arteries in the legs. Half were randomly assigned to receive IVUS plus angiography and half received angiography alone.

Peripheral Arterial Disease 116

Peripheral Arterial Disease Ultrasound Angioplasty Plaque 116

Medical Xpress - Cardiology

SEPTEMBER 2, 2024

Novel drug-coated balloons (DCB) did not outshine standard treatment with second generation drug-eluting stents (DES) as they were expected to, in a surprise finding of the first randomized trial to compare clinical outcomes in previously untreated patients with non-complex disease undergoing percutaneous coronary intervention (PCI).

Stents 45

Stents Stent Angioplasty Outcomes 45

Journal of Cardiovascular Electrophysiology

NOVEMBER 20, 2024

Balloon angioplasty seems to be the widely preferred treatment of choice. The stenosis was treated with a stent. years later he presented with an in-stent restenosis that was successfully treated with a stent-in-stent strategy. The stenosis was treated with a stent.

Stents 40

Stents Stent Pulmonary Angioplasty 40

DAIC

MAY 3, 2024

Around 10% of Deaths from Coronary Stenting, Balloon Angioplasty are Preventable 9. Heartmate II and Heartmate 3 Left Ventricular Assist System (LVAS) Due to Long-term Buildup of biological material Causing an Obstruction 8. EMPACT-MI Trial Outcomes Reported at ACC.24: 24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack 10.

Angioplasty 105

Angioplasty Blood Pressure Heart Attack Heart attacks 105

Know Your Heart

FEBRUARY 20, 2019

Coronary Artery Stents What are coronary artery stents? A stent is a tiny device made of surgical stainless steel that is placed inside an artery to hold it open and allow blood to flow through the blood vessel. When are coronary stents used? Coronary stents are used as a routine part of most angioplasty procedures.

Stents 40

Stents Stent Angioplasty 40

Cardiology Update

MARCH 25, 2024

Pooled data from four trials were analyzed, encompassing patients undergoing PCI or CABG for left main disease.

Diabetes 122

Diabetes Coronary Artery Bypass Graft Outcomes Coronary Artery Disease 122

Med Page Today

APRIL 30, 2024

(MedPage Today) -- For patients with peripheral artery disease (PAD) and chronic limb-threatening ischemia, drug-eluting stents and drug-coated balloons did not improve amputation-free survival compared with balloon angioplasty alone in the BASIL.

Peripheral Arterial Disease 64

Peripheral Arterial Disease Angioplasty Heart Disease Cancer 64

Stroke Journal

FEBRUARY 1, 2024

Introduction:Traditional endovascular treatment for acutely symptomatic intracranial atherosclerotic disease (ICAD) includes balloon angioplasty and stenting. Catheter mediated angioplasty (or “Dotter” angioplasty) has been previously described for extracranial carotid and peripheral arteries.

Angioplasty 40

Angioplasty Stenosis Stents Stent 40

Stroke Journal

JANUARY 30, 2025

Introduction:Medical therapy and endovascular therapy for intracranial atherosclerotic disease (ICAD) have evolved over the past two decades with improved medical therapy benchmarks, and improved techniques and patient selection for stenting.

Stents 40

Stents Stent Inpatient Angioplasty 40

American College of Cardiology

MARCH 20, 2024

The goal of the AGENT IDE trial was to assess the safety and efficacy of a paclitaxel-coated balloon (drug-coated balloon; DCB) to conventional balloon angioplasty among patients with coronary in-stent restenosis (ISR).

Stents 42

Stents Stent Angioplasty Article 42

The American Journal of Cardiology

JULY 18, 2024

Publication date: Available online 18 July 2024 Source: The American Journal of Cardiology Author(s): Safia Shaikh, Mohammad Hamza, Prakash Upreti, Mohammad Akkawi, Kripa Rajak, Mobeen Zaka Haider, Nomesh Kumar, Mustafa Turkmani, Fadi Kathawa, Salman Abdul Basit, Yasemin Bahar, Sadaf Fakhra, Yasar Sattar, M Chadi Alraies

Angioplasty 52

Angioplasty Stents Stent 52

Stroke Journal

FEBRUARY 1, 2024

In cases of stent-retriever thrombectomy failure, rescue stent angioplasty might be the sole option for achieving permanent recanalization. Among patients who underwent emergency intracranial stenting, 66 (30.6%) received intravenous thrombolytic treatment. 10.43, p=0.0325).Conclusions:The 10.43, p=0.0325).Conclusions:The

Stents 40

Stents Stent Thrombolysis Angioplasty 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Rescue treatment with stenting, balloon angioplasty, and/or intraarterial thrombolysis or antiplatelets are often required to treat the underlying stenosis. 4 Recent literature has reported clinical benefits associated with rescue stenting in the setting of ICAD‐related MT‐refractory strokes.5

Stents 40

Stents Stent Circulation Stroke 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

The role of intracranial stenting in ICAS remains uncertain. In the SAMMPRIS trial, patients who had experienced recent TIA/CVA secondary to 70‐99% ICAS demonstrated an increased risk of recurrent stroke when treated with angioplasty and stenting compared to medical therapy alone [1].

Stents 40

Stents Stent Outcomes Angioplasty 40

American College of Cardiology

MARCH 20, 2024

He then discusses paclitaxel-coated balloon catheters vs uncoated balloon angioplasty for treating coronary in-stent restenosis. Eagle looks at the difference between quantitative coronary angiography versus intervascular ultrasound to guide PCI.

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Ultrasound Angioplasty Stents 52

Stroke Journal

JANUARY 30, 2025

All patients had headache, and funduscopic examination demonstrated papilledema for all patients. All patients had headache, and funduscopic examination demonstrated papilledema for all patients. All patients had headache, and funduscopic examination demonstrated papilledema for all patients.

Stents 40

Stents Stent Stenosis Angioplasty 40

American College of Cardiology

OCTOBER 29, 2024

The goal of the ECLIPSE trial was to evaluate orbital atherectomy prior to drug-eluting stent (DES) implantation compared with conventional percutaneous coronary intervention (PCI) without atherectomy among patients with calcified coronary lesions.

Angioplasty 46

Angioplasty Stents Stent Article 46

Med Page Today

SEPTEMBER 2, 2024

(MedPage Today) -- LONDON -- Drug-coated balloon (DCB) angioplasty as the initial strategy for de novo coronary artery stenoses didn't measure up to stenting from the start, the REC-CAGEFREE I randomized trial showed. DCB with rescue use of.

Angioplasty 52

Angioplasty Stents Stent 52

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Recent research has identified venous sinus stenosis as a cause of IIH, a common treatment of which is venous stenting and angioplasty. An adverse event of this procedure is in‐stent stenosis (ISS), due to either neointimal hyperplasia or hypersensitivity to an element in the stent.

Stents 40

Stents Stent Hypertension Stenosis 40

Frontiers in Cardiovascular Medicine

DECEMBER 3, 2024

A bare metal stent (BMS) may protect LGO, according to the hypothesis of this single-center retrospective analysis.MethodsAll patients undergoing elective EVAR with a bifurcated stent graft between January 2012 and June 2022 were included in this cohort study. At a mean follow-up imaging duration of 28.7 ± 23.6 months

Aneurysm 40

Aneurysm Stents Stent Angioplasty 40

DAIC

APRIL 12, 2024

If a physician fails to cross a CTO, minimally invasive revascularization options such as angioplasty and stent placement cannot be performed. Hence, in the US, many CTO patients are instead sent for bypass surgery.

Technology 111

Technology Cardiovascular Interventions Coronary Artery Disease Innovation 111

Frontiers in Cardiovascular Medicine

MARCH 19, 2024

Drug-eluting balloons, as a new type of endovascular interventional treatment option, can avoid the long-term implantation of metal stents and is a new type of angioplasty without stents, so drug-eluting balloons have better therapeutic effects in some arterial circulatory diseases and have been initially used in clinical practice.

Research 49

Research Stents Stent Angioplasty 49

Circulation: Cardiovascular Interventions

FEBRUARY 13, 2024

BACKGROUND:The treatment of complex infra-inguinal disease with drug-coated balloons (DCBs) is associated with a significant number of patients undergoing provisional stenting to treat a suboptimal result. stented versus 70.0% stented versus 68.2% stented versus 45.0% stented versus 19.3% stented versus 45.0%

Stents 40

Stents Stent Angioplasty Cardiovascular Interventions 40